1. Proceedings of Conference on Evaluation and management of salivary gland dysfunction. Bethesda, 1986, 15-16 May. J. Dent. Res. 66, (1987)622-708, Special Issue. J.A. Aarly. Immunological aspects of epilepsy. Brain Dev. 15, (1993)41–50.
2. Agha-Hosseini F., I. Mirzaii-Dizgah, L. Ghavamzadeh, A. Ghavanzadeh en Z. Tohidast-Acrad. Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant. 39, (2007)431–434.
3. Aono M., V.L.N. Murthy, H. Witas, A. Slomiany en B.L. Slomiany. Lipids of submandibular saliva in cystic fibrosis. IRCS Med. Sci. 10, (1982)159.
4. Aps J.K.M. Assessment of the status praesens, including the determining factors, of oral health in cystic fibrosis homozygotes and heterozygotes in Belgium. Thesis Universiteit Gent, Gent, Belgium, 2002.
5. Aps J.K.M., J. Delanghe en L.C. Martens. Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes. Clin. Chem. Lab Med. 40, (2002)345–350.